Drugs / PRO-157
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02980523 | Mar 2015 → Jun 2016 | bacterial conjunctivitis | Laboratorios Sophia S.A de C.V. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PRO-157 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02980523 ↗ |
| Route | Other | “instill one drop in each eye of PRO-157 (pazufloxacin), every 12 hours per day (BID), for 7 days” NCT02980523 ↗ |